J. Szanto - Academia.edu (original) (raw)
Uploads
Papers by J. Szanto
Radiotherapy and Oncology, 2012
than 10 mm. Our approach is to develop a phantom that contains an embedded array of plastic scint... more than 10 mm. Our approach is to develop a phantom that contains an embedded array of plastic scintillators coupled to square air core light guides. The prototype array allows for accurate verification of fields as small as 4 mm, with high spatial and temporal resolution and without the need for correction factors. Materials and Methods: The 16 element linear array was constructed from custom cut PMMA sheets. Plastic scintillation detectors (BC400) of volume 0.8 mm3 were placed in 1 x 1 mm silvered square air core waveguides to avoid the production of a Cerenkov background signal in the primary field. The 16 detector elements have a center-tocenter spacing of 2 mm and an edge-to-edge distance of 1 mm and provide high resolution profiles of small treatment fields and of high dose gradients.Scintillation light from the air core array was measured with a photomultiplier tube (PMT) array detector, enabling measurements with high temporal resolution (10 Hz). This scintillation light readout system and user interface software was optimized for clinical use.The array was placed in a water equivalent medium in order to measure the beam output factors, percentage depth dose and beam profiles of radiation fields produced by a Varian Novalis TX linac. The array was then displaced laterally three times for measuring the beam profile, increasing the array's spatial resolution to 0.5 mm. Results: The PMMA light guides of 1 mm square cross section and 180 mm length show 5 times more light transmission than the previously used circular light guides of 1 mm diameter of the same length. The dose measurements were compared to those measured using a single air core dosimeter and other commercially available dosimeters. This experimentally confirms the suitability of the air core array for small field dosimetry with no corrections needed for angular dependence or dose perturbation as currently required by commercial arrays.
Radiotherapy and Oncology, 2006
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique, 2003
To identify SF2 as a prognostic factor of late complications from radiosurgery in patients treate... more To identify SF2 as a prognostic factor of late complications from radiosurgery in patients treated for AVM. Five patients with AVM treated in three canadian institutions and who suffered clinically significant neurological sequelaes secondary to radiosurgery were identified. Their fibroblasts were cultured and their radiation sensitivity tested to determine the SF2 for each patient. Patients who developed a neurological complication from radionecrosis, secondary to radiosurgery had an SF2 different than the two control patients with AVM and no complications and also from a group of five cancer patients without late radiation complications (P = 0.005). Radiosurgery is an elective procedure. The identification of a subgroup of patients who are radiosensitive and at a higher risk of radiation induced complications can allow the treatment team to reduce the risk of such complications. SF2 as a new predictive factor should be incorporated in predictive models of risk from treatment of AV...
Radiotherapy and Oncology, 1996
Trends in Food Science & Technology, 1993
Physics in Medicine and Biology, 1994
International Journal of Radiation Oncology*Biology*Physics, 2012
International Journal of Radiation Oncology*Biology*Physics, 2012
International Journal of Radiation Oncology*Biology*Physics, 1996
International Journal of Radiation Oncology*Biology*Physics, 1992
International Journal of Radiation Oncology*Biology*Physics, 1998
International Journal of Radiation Oncology*Biology*Physics, 2000
International Journal of Radiation Oncology*Biology*Physics, 1992
International Journal of Radiation Oncology*Biology*Physics, 1998
International Journal of Radiation Oncology*Biology*Physics, 2000
International Journal of Radiation Oncology*Biology*Physics, 2000
Radiotherapy and Oncology, 2012
than 10 mm. Our approach is to develop a phantom that contains an embedded array of plastic scint... more than 10 mm. Our approach is to develop a phantom that contains an embedded array of plastic scintillators coupled to square air core light guides. The prototype array allows for accurate verification of fields as small as 4 mm, with high spatial and temporal resolution and without the need for correction factors. Materials and Methods: The 16 element linear array was constructed from custom cut PMMA sheets. Plastic scintillation detectors (BC400) of volume 0.8 mm3 were placed in 1 x 1 mm silvered square air core waveguides to avoid the production of a Cerenkov background signal in the primary field. The 16 detector elements have a center-tocenter spacing of 2 mm and an edge-to-edge distance of 1 mm and provide high resolution profiles of small treatment fields and of high dose gradients.Scintillation light from the air core array was measured with a photomultiplier tube (PMT) array detector, enabling measurements with high temporal resolution (10 Hz). This scintillation light readout system and user interface software was optimized for clinical use.The array was placed in a water equivalent medium in order to measure the beam output factors, percentage depth dose and beam profiles of radiation fields produced by a Varian Novalis TX linac. The array was then displaced laterally three times for measuring the beam profile, increasing the array's spatial resolution to 0.5 mm. Results: The PMMA light guides of 1 mm square cross section and 180 mm length show 5 times more light transmission than the previously used circular light guides of 1 mm diameter of the same length. The dose measurements were compared to those measured using a single air core dosimeter and other commercially available dosimeters. This experimentally confirms the suitability of the air core array for small field dosimetry with no corrections needed for angular dependence or dose perturbation as currently required by commercial arrays.
Radiotherapy and Oncology, 2006
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique, 2003
To identify SF2 as a prognostic factor of late complications from radiosurgery in patients treate... more To identify SF2 as a prognostic factor of late complications from radiosurgery in patients treated for AVM. Five patients with AVM treated in three canadian institutions and who suffered clinically significant neurological sequelaes secondary to radiosurgery were identified. Their fibroblasts were cultured and their radiation sensitivity tested to determine the SF2 for each patient. Patients who developed a neurological complication from radionecrosis, secondary to radiosurgery had an SF2 different than the two control patients with AVM and no complications and also from a group of five cancer patients without late radiation complications (P = 0.005). Radiosurgery is an elective procedure. The identification of a subgroup of patients who are radiosensitive and at a higher risk of radiation induced complications can allow the treatment team to reduce the risk of such complications. SF2 as a new predictive factor should be incorporated in predictive models of risk from treatment of AV...
Radiotherapy and Oncology, 1996
Trends in Food Science & Technology, 1993
Physics in Medicine and Biology, 1994
International Journal of Radiation Oncology*Biology*Physics, 2012
International Journal of Radiation Oncology*Biology*Physics, 2012
International Journal of Radiation Oncology*Biology*Physics, 1996
International Journal of Radiation Oncology*Biology*Physics, 1992
International Journal of Radiation Oncology*Biology*Physics, 1998
International Journal of Radiation Oncology*Biology*Physics, 2000
International Journal of Radiation Oncology*Biology*Physics, 1992
International Journal of Radiation Oncology*Biology*Physics, 1998
International Journal of Radiation Oncology*Biology*Physics, 2000
International Journal of Radiation Oncology*Biology*Physics, 2000